BRIDGET MCKINLEY: Open Payments
NPI 1720427115 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,396 in 78 payments from 16 companies in 2025. Trend: 2023 $1,585 · 2024 $1,618 · 2025 $1,396
Food & beverage: $1,396
| Company | Payments | Amount |
|---|---|---|
| Insmed, Inc. | 14 | $272 |
| AstraZeneca Pharmaceuticals LP | 10 | $245 |
| GENZYME CORPORATION | 14 | $216 |
| GlaxoSmithKline, LLC. | 16 | $215 |
| Actelion Pharmaceuticals US, Inc. | 4 | $101 |
| Viatris Specialty LLC | 3 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $47 |
| Verona Pharma, Inc. | 3 | $45 |
| Amgen Inc. | 2 | $34 |
| Merck Sharp & Dohme LLC | 2 | $33 |
Products named: Arikayce, DUPIXENT, NUCALA, BREZTRI, UPTRAVI, YUPELRI, FASENRA, Ohtuvayre.
Industry payments across KY — which companies pay providers there.
